BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

December 20, 2023

https://www.globenewswire.com/news-release/2023/12/20/2799219/0/en/BioAtla-to-Participate-in-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html

SAN DIEGO, Dec. 20, 2023 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq:BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that the Company’s management will participate in a fireside chat and one-on-one investor meetings at the 42nd Annual J.P. Morgan Healthcare Conference, to be held in San Francisco, CA January 8-11, 2024.

Read more at globenewswire.com

Related news for (BCAB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.